LimFlow wins FDA nod for pDVA trial in chronic limb-threatening ischemia - Mass Device

LimFlow wins FDA nod for pDVA trial in chronic limb-threatening ischemia  Mass Device

LimFlow said today that it won an investigational device exemption from the FDA for a pivotal trial of its catheter-based intervention for a severe form of ...